Canada Life
FLNA

Canada Life’s Filana Therapeutics FLNA Stock Holding History

Canada Life’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,380
Closed -$27K – 2018
2024
Q4 		$27K Buy
11,380
+7,566
+198% +$133K ﹤0.01% 1931
2024
Q3 		$112K Sell
3,814
-9,594
-72% -$221K ﹤0.01% 1850
2024
Q2 		$165K Buy
13,408
+4,000
+43% +$84.3K ﹤0.01% 1827
2024
Q1 		$191K Buy
9,408
+5,594
+147% +$129K ﹤0.01% 1835
2023
Q4 		$85K Sell
3,814
-1,258
-25% -$26.6K ﹤0.01% 1978
2023
Q3 		$84K Buy
5,072
+3,008
+146% +$59.6K ﹤0.01% 2003
2023
Q2 		$51K Hold
2,064
– – ﹤0.01% 2004
2023
Q1 		$50K Hold
2,064
– – ﹤0.01% 2069
2022
Q4 		$61K Hold
2,064
– – ﹤0.01% 2055
2022
Q3 		$86K Hold
2,064
– – ﹤0.01% 2014
2022
Q2 		$58K Hold
2,064
– – ﹤0.01% 2031
2022
Q1 		$81K Hold
2,064
– – ﹤0.01% 2043
2021
Q4 		$90K Hold
2,064
– – ﹤0.01% 2035
2021
Q3 		$129K Hold
2,064
– – ﹤0.01% 1998
2021
Q2 		$176K Buy
+2,064
New +$111K ﹤0.01% 1955
2015
Q3 		– Sell
-18
Closed – – 2541
2015
Q2 		$0 Hold
18
– – ﹤0.01% 2679
2015
Q1 		$0 Hold
18
– – ﹤0.01% 2582
2014
Q4 		$0 Hold
18
– – ﹤0.01% 2570
2014
Q3 		$0 Hold
18
– – ﹤0.01% 2524
2014
Q2 		$1K Buy
+18
New +$666 ﹤0.01% 2403

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Canada Life's FLNA Position: Q1 2025 in Review

Canada Life sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 11,380 shares — an estimated $27K sold.

Canada Life first reported a position in FLNA in Q2 2014 and held it in 20 quarters. The position peaked at $191K in Q1 2024. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

  • Canada Life reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Canada Life sold 11,380 Filana Therapeutics shares in Q1 2025, an estimated $27K.
  • Canada Life first reported a position in Filana Therapeutics in Q2 2014 and held it in 20 quarters.
  • Canada Life's Filana Therapeutics position peaked at $191K in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on Canada Life's 13F filing for Q1 2025, filed 15 May 2025.